Perioperative Therapy for Hepatocellular Carcinoma

NCT04653389 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped The treatment efficacy was not satisfactory.

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sintilimab Injection
DRUG: TACE
RADIATION: Radiotherapy

Sponsor

Zhejiang University